Logo image of ARQQ

ARQIT QUANTUM INC (ARQQ) Stock Fundamental Analysis

USA - NASDAQ:ARQQ - KYG0567U1278 - Common Stock

41.2 USD
+2.45 (+6.32%)
Last: 10/1/2025, 8:23:07 PM
41 USD
-0.2 (-0.49%)
After Hours: 10/1/2025, 8:23:07 PM
Fundamental Rating

2

Taking everything into account, ARQQ scores 2 out of 10 in our fundamental rating. ARQQ was compared to 281 industry peers in the Software industry. While ARQQ seems to be doing ok healthwise, there are quite some concerns on its profitability. ARQQ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ARQQ has reported negative net income.
In the past year ARQQ has reported a negative cash flow from operations.
ARQQ had negative earnings in 4 of the past 5 years.
ARQQ had a negative operating cash flow in each of the past 5 years.
ARQQ Yearly Net Income VS EBIT VS OCF VS FCFARQQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

The Return On Assets of ARQQ (-204.28%) is worse than 95.02% of its industry peers.
Looking at the Return On Equity, with a value of -461.85%, ARQQ is doing worse than 84.70% of the companies in the same industry.
Industry RankSector Rank
ROA -204.28%
ROE -461.85%
ROIC N/A
ROA(3y)-74.09%
ROA(5y)-45.92%
ROE(3y)-161.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARQQ Yearly ROA, ROE, ROICARQQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ARQQ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARQQ Yearly Profit, Operating, Gross MarginsARQQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

5

2. Health

2.1 Basic Checks

ARQQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ARQQ has been reduced compared to 1 year ago.
The debt/assets ratio for ARQQ has been reduced compared to a year ago.
ARQQ Yearly Shares OutstandingARQQ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
ARQQ Yearly Total Debt VS Total AssetsARQQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 12.06 indicates that ARQQ is not in any danger for bankruptcy at the moment.
The Altman-Z score of ARQQ (12.06) is better than 87.90% of its industry peers.
ARQQ has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.06, ARQQ perfoms like the industry average, outperforming 57.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 12.06
ROIC/WACCN/A
WACC9.98%
ARQQ Yearly LT Debt VS Equity VS FCFARQQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 1.94 indicates that ARQQ should not have too much problems paying its short term obligations.
The Current ratio of ARQQ (1.94) is better than 60.14% of its industry peers.
ARQQ has a Quick Ratio of 1.94. This is a normal value and indicates that ARQQ is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.94, ARQQ is doing good in the industry, outperforming 61.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.94
ARQQ Yearly Current Assets VS Current LiabilitesARQQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.58% over the past year.
Looking at the last year, ARQQ shows a very negative growth in Revenue. The Revenue has decreased by -68.25% in the last year.
EPS 1Y (TTM)58.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.47%
Revenue 1Y (TTM)-68.25%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-43.7%

3.2 Future

The Earnings Per Share is expected to grow by 28.24% on average over the next years. This is a very strong growth
Based on estimates for the next years, ARQQ will show a very strong growth in Revenue. The Revenue will grow by 783.92% on average per year.
EPS Next Y28.76%
EPS Next 2Y27.61%
EPS Next 3Y28.24%
EPS Next 5YN/A
Revenue Next Year149.19%
Revenue Next 2Y258.4%
Revenue Next 3Y783.92%
Revenue Next 5YN/A

3.3 Evolution

ARQQ Yearly Revenue VS EstimatesARQQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M
ARQQ Yearly EPS VS EstimatesARQQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ARQQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ARQQ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARQQ Price Earnings VS Forward Price EarningsARQQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARQQ Per share dataARQQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

A more expensive valuation may be justified as ARQQ's earnings are expected to grow with 28.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.61%
EPS Next 3Y28.24%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ARQQ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARQIT QUANTUM INC

NASDAQ:ARQQ (10/1/2025, 8:23:07 PM)

After market: 41 -0.2 (-0.49%)

41.2

+2.45 (+6.32%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-22 2025-05-22/bmo
Earnings (Next)12-03 2025-12-03/amc
Inst Owners12%
Inst Owner Change0%
Ins Owners8.72%
Ins Owner ChangeN/A
Market Cap555.38M
Analysts82.86
Price Target53.04 (28.74%)
Short Float %18.08%
Short Ratio1.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-131.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-79.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1895.48
P/FCF N/A
P/OCF N/A
P/B 46.99
P/tB 56.22
EV/EBITDA N/A
EPS(TTM)-3.26
EYN/A
EPS(NY)-1.71
Fwd EYN/A
FCF(TTM)-2.78
FCFYN/A
OCF(TTM)-2.53
OCFYN/A
SpS0.02
BVpS0.88
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -204.28%
ROE -461.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-74.09%
ROA(5y)-45.92%
ROE(3y)-161.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1135.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.94
Altman-Z 12.06
F-Score3
WACC9.98%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1331.14%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.47%
EPS Next Y28.76%
EPS Next 2Y27.61%
EPS Next 3Y28.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-68.25%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-43.7%
Revenue Next Year149.19%
Revenue Next 2Y258.4%
Revenue Next 3Y783.92%
Revenue Next 5YN/A
EBIT growth 1Y67.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.54%
EBIT Next 3Y63.99%
EBIT Next 5YN/A
FCF growth 1Y23.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.95%
OCF growth 3YN/A
OCF growth 5YN/A